NASDAQ:IDYA

Ideaya Biosciences Stock Insider Trading

etoro logo Buy IDYA
*Your capital is at risk
$28.40
+0.530 (+1.90%)
At Close: Jun 03, 2026

IDEAYA Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 6.2M and sold 407K IDYA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 6.2M shares
Sell 407K shares
82% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 02, 2026
Buy
Common Stock
P-Purchase
Stein Jeffrey
Director
Director 50 000
Value: $1.65M
Jan 30, 2026
Buy
Stock Option (right to buy)
A-Award
Dorman Stuart
Chief Commercial Officer
Officer 155 000
Value: $4.99M
Jan 30, 2026
Buy
Stock Option (right to buy)
A-Award
Beaupre Darrin
Chief Medical Officer
Officer 175 000
Value: $5.63M
Jan 30, 2026
Buy
Stock Option (right to buy)
A-Award
White Michael Anthony
Chief Scientific Officer
Officer 190 000
Value: $6.12M
Jan 30, 2026
Buy
Stock Option (right to buy)
A-Award
Bleharski Joshua
Chief Financial Officer
C-Suite Officer 170 000
Value: $5.47M
Jan 30, 2026
Buy
Stock Option (right to buy)
A-Award
Hata Yujiro S
President And CEO
CEO / President 600 000
Value: $19.3M
Jan 30, 2026
Buy
Stock Option (right to buy)
A-Award
Snyder Douglas B.
SVP, General Counsel
Officer 130 000
Value: $4.18M
Jan 30, 2026
Buy
Stock Option (right to buy)
A-Award
Ruiz Briseno Andres
See Remarks
Officer 80 000
Value: $2.58M
Nov 28, 2025
Buy
Common Stock
A-Award
Snyder Douglas B.
SVP, General Counsel
Officer 1 041
Value: $17.6K
Nov 28, 2025
Buy
Common Stock
A-Award
Ruiz Briseno Andres
See Remarks
Officer 1 253
Value: $21.2K
Jun 27, 2025
Buy
Stock Option (right to buy)
Bleharski Joshua
Chief Financial Officer
C-Suite Officer 250 000
Value: $5.01M
Jun 27, 2025
Buy
Stock Option (right to buy)
Bleharski Joshua
Chief Financial Officer
C-Suite Officer 250 000
Value: $5.01M
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Yarno Wendy L
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Stein Jeffrey
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Hampton Malcolm Garret
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Morrison Scott W
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Mackey Catherine J
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Rosen Terry J
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Rosen Terry J
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Mackey Catherine J
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Morrison Scott W
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Hampton Malcolm Garret
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Stein Jeffrey
Director
Director 20 000
Value: $435.6K
Jun 24, 2025
Buy
Stock Option (right to buy)
A-Award
Yarno Wendy L
Director
Director 20 000
Value: $435.6K
May 30, 2025
Buy
Common Stock
A-Award
Snyder Douglas B.
SVP, General Counsel
Officer 1 039
Value: $17.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IDEAYA BIOSCIENCES INC.
IDEAYA Biosciences
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE